Literature DB >> 32929232

Exercise and immunometabolic regulation in cancer.

Graeme J Koelwyn1, Xueqian Zhuang2, Tuomas Tammela2,3, Andrea Schietinger4,5, Lee W Jones6,7.   

Abstract

Unhealthful lifestyle factors, such as obesity, disrupt organismal homeostasis and accelerate cancer pathogenesis, partly through metabolic and immunological dysregulation. Exercise is a prototypical strategy that maintains and restores homeostasis at the organismal, tissue, cellular and molecular levels and can prevent or inhibit numerous disease conditions, including cancer. Here, we review unhealthful lifestyle factors that contribute to metabolic and immunological dysregulation and drive tumourigenesis, focusing on patient physiology (host)-tissue-tumour microenvironment interactions. We also discuss how exercise may influence distant tissue microenvironments, thereby improving tissue function through both metabolic and immunospecific pathways. Finally, we consider future directions that merit consideration in basic and clinical translational exercise studies.

Entities:  

Mesh:

Year:  2020        PMID: 32929232      PMCID: PMC9128397          DOI: 10.1038/s42255-020-00277-4

Source DB:  PubMed          Journal:  Nat Metab        ISSN: 2522-5812


  95 in total

1.  SnapShot: Exercise Metabolism.

Authors:  Brendan Egan; John A Hawley; Juleen R Zierath
Journal:  Cell Metab       Date:  2016-08-09       Impact factor: 27.287

Review 2.  Metabolic Regulation of Macrophage Polarization in Cancer.

Authors:  Kamiya Mehla; Pankaj K Singh
Journal:  Trends Cancer       Date:  2019-11-06

Review 3.  A clinical and biological perspective of human myeloid-derived suppressor cells in cancer.

Authors:  Christopher Shipp; Lisa Speigl; Nicole Janssen; Alexander Martens; Graham Pawelec
Journal:  Cell Mol Life Sci       Date:  2016-05-28       Impact factor: 9.261

4.  Effect of a 12-month exercise intervention on patterns of cellular proliferation in colonic crypts: a randomized controlled trial.

Authors:  Anne McTiernan; Yutaka Yasui; Bess Sorensen; Melinda L Irwin; Angela Morgan; Rebecca E Rudolph; Christina Surawicz; Johanna W Lampe; Kamran Ayub; John D Potter; Paul D Lampe
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-09       Impact factor: 4.254

5.  The cellular and molecular origin of tumor-associated macrophages.

Authors:  Ruth A Franklin; Will Liao; Abira Sarkar; Myoungjoo V Kim; Michael R Bivona; Kang Liu; Eric G Pamer; Ming O Li
Journal:  Science       Date:  2014-05-08       Impact factor: 47.728

6.  Heart Failure Stimulates Tumor Growth by Circulating Factors.

Authors:  Wouter C Meijers; Manuel Maglione; Stephan J L Bakker; Rupert Oberhuber; Lyanne M Kieneker; Steven de Jong; Bernhard J Haubner; Wouter B Nagengast; Alexander R Lyon; Bert van der Vegt; Dirk J van Veldhuisen; B Daan Westenbrink; Peter van der Meer; Herman H W Silljé; Rudolf A de Boer
Journal:  Circulation       Date:  2018-08-14       Impact factor: 29.690

7.  Dysregulated hematopoiesis caused by mammary cancer is associated with epigenetic changes and hox gene expression in hematopoietic cells.

Authors:  Alexander Sio; Manreet K Chehal; Kevin Tsai; Xueling Fan; Morgan E Roberts; Brad H Nelson; Jolanta Grembecka; Tomasz Cierpicki; Danielle L Krebs; Kenneth W Harder
Journal:  Cancer Res       Date:  2013-08-01       Impact factor: 12.701

Review 8.  The role of myeloid cells in cancer therapies.

Authors:  Camilla Engblom; Christina Pfirschke; Mikael J Pittet
Journal:  Nat Rev Cancer       Date:  2016-07       Impact factor: 60.716

9.  Circulating hematopoietic stem and progenitor cells are myeloid-biased in cancer patients.

Authors:  Wen-Chao Wu; Hong-Wei Sun; Hai-Tian Chen; Jing Liang; Xing-Juan Yu; Chong Wu; Zilian Wang; Limin Zheng
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-03       Impact factor: 11.205

10.  Improving the metabolic fidelity of cancer models with a physiological cell culture medium.

Authors:  Johan Vande Voorde; Tobias Ackermann; Nadja Pfetzer; David Sumpton; Gillian Mackay; Gabriela Kalna; Colin Nixon; Karen Blyth; Eyal Gottlieb; Saverio Tardito
Journal:  Sci Adv       Date:  2019-01-02       Impact factor: 14.136

View more
  7 in total

1.  Run for your life: an integrated virtual tissue platform for incorporating exercise oncology into immunotherapy.

Authors:  Josua Aponte Serrano; Amit Hagar
Journal:  Cancer Immunol Immunother       Date:  2021-01-08       Impact factor: 6.968

2.  Effect of a 3-Year Lifestyle Intervention in Patients with Chronic Kidney Disease: A Randomized Clinical Trial.

Authors:  Kassia S Beetham; Rathika Krishnasamy; Tony Stanton; Julian W Sacre; Bettina Douglas; Nicole M Isbel; Jeff S Coombes; Erin J Howden
Journal:  J Am Soc Nephrol       Date:  2021-12-10       Impact factor: 10.121

3.  Enabling exercise prescription for survivors of cancer.

Authors:  Katherine R White; Jana Lu; Zara Ibrahim; Priscilla A Furth
Journal:  Sci Rep       Date:  2021-05-05       Impact factor: 4.996

Review 4.  Reverse cardio-oncology: Exploring the effects of cardiovascular disease on cancer pathogenesis.

Authors:  Graeme J Koelwyn; Joseph Pierre Aboumsallem; Kathryn J Moore; Rudolf A de Boer
Journal:  J Mol Cell Cardiol       Date:  2021-09-25       Impact factor: 5.000

Review 5.  Personalized Medicine for Prostate Cancer: Is Targeting Metabolism a Reality?

Authors:  Gio Fidelito; Matthew J Watt; Renea A Taylor
Journal:  Front Oncol       Date:  2022-01-21       Impact factor: 6.244

6.  Pre-operative exercise therapy triggers anti-inflammatory trained immunity of Kupffer cells through metabolic reprogramming.

Authors:  Hongji Zhang; Tianmeng Chen; Jinghua Ren; Yujia Xia; Amblessed Onuma; Yu Wang; Jiayi He; Junru Wu; Han Wang; Ahmad Hamad; Chengli Shen; Jinxiang Zhang; John M Asara; Gregory K Behbehani; Haitao Wen; Meihong Deng; Allan Tsung; Hai Huang
Journal:  Nat Metab       Date:  2021-06-14

7.  Arachidonic Acid Metabolism Controls Macrophage Alternative Activation Through Regulating Oxidative Phosphorylation in PPARγ Dependent Manner.

Authors:  Miao Xu; Xiaohong Wang; Yongning Li; Xue Geng; Xudong Jia; Lishi Zhang; Hui Yang
Journal:  Front Immunol       Date:  2021-06-03       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.